The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan Kuniko SunamiYoichi NaitoTakayuki Yoshino Special Article Open access 01 January 2021 Pages: 443 - 449
Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis Pipit BurasakarnRyota HiguchiJapan Duodenal Cancer Guideline Committee Review Article 01 January 2021 Pages: 450 - 460
Cryoablation, high-intensity focused ultrasound, irreversible electroporation, and vascular-targeted photodynamic therapy for prostate cancer: a systemic review and meta-analysis Run-Qi GuoXiao-Xiao GuoXiao-Guang Li Review Article 02 January 2021 Pages: 461 - 484
Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan Shohei NakamuraYusuke KanemasaAkifumi Imamura Original Article 23 November 2020 Pages: 485 - 493
Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study Nobuhiro HanaiYasushi ShimizuAkihiro Homma Original Article Open access 21 November 2020 Pages: 494 - 506
Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer Tsukasa HasegawaNoriko YanagitaniMakoto Nishio Original Article 07 November 2020 Pages: 507 - 514
Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302 Yosuke KawashimaToshiyuki HaradaShunichi Sugawara Original Article 13 November 2020 Pages: 515 - 522
Association between skeletal muscle loss and the response to nivolumab immunotherapy in advanced gastric cancer patients Mikihiro KanoJun HiharaShinya Takahashi Original Article 23 November 2020 Pages: 523 - 531
TRIM37 overexpression is associated with chemoresistance in hepatocellular carcinoma via activating the AKT signaling pathway Guosheng TanBinhui XieHeping Li Original Article 02 January 2021 Pages: 532 - 542
Risk factors for gemcitabine plus nab-paclitaxel-induced interstitial lung disease in pancreatic cancer patients Tsuyoshi TakedaTakashi SasakiNaoki Sasahira Original Article 11 November 2020 Pages: 543 - 551
Predictive role of γ-glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma Yudai IshiyamaTsunenori KondoKazunari Tanabe Original Article 01 November 2020 Pages: 552 - 561
Oncologic outcomes and safety of percutaneous cryoablation for biopsy-proven renal cell carcinoma up to 4 cm in diameter: a prospective observational study Hideo GobaraTakao HirakiSusumu Kanazawa Original Article 10 November 2020 Pages: 562 - 568
The metabolic syndrome is associated with the risk of urothelial carcinoma from a health examination database Hsiang-Ying LeeJia-Hong TangTa-Chien Chan Original Article 24 November 2020 Pages: 569 - 577
Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial Hiroji UemuraHisashi MatsushimaKazuhiro Suzuki Original Article Open access 23 November 2020 Pages: 578 - 590
The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model Masahiro KagabuNaoto YoshinoToru Sugiyama Original Article 04 November 2020 Pages: 591 - 597
Bevacizumab-associated events in Japanese women with cervical cancer: a multi-institutional survey of Obstetrical Gynecological Society of Kinki district, Japan Seiji MabuchiMisa YamamotoSho Matsubara Original Article 13 November 2020 Pages: 598 - 605
Risk factors for lymph node metastasis in cutaneous squamous cell carcinoma: a long-term retrospective study of Japanese patients Yuki SaitoHiroki FujikawaTatsuya Takenouchi Original Article 11 November 2020 Pages: 606 - 612
Diagnostic accuracies of intraoperative frozen section and permanent section examinations for histological grades during open biopsy of bone tumors Shinji MiwaNorio YamamotoHiroyuki Tsuchiya Original Article 23 November 2020 Pages: 613 - 619
Is it a case series? Comment on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei” Min LuoYetao Li Letter to the Editor 01 January 2021 Pages: 620 - 620
Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei” Sakura HiraideKeigo KomineChikashi Ishioka Letter to the Editor Open access 06 February 2021 Pages: 621 - 621
